DiscoverStroke News & Brain Health - American Heart AssociationPCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke
PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke

PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke

Update: 2025-11-08
Share

Description

Research Highlights:


Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or stroke, the PCSK9 inhibitor...
Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke

PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke